Continuing Quarterly Trend, LabCorp Trounces Quest in Q2 Revenue, Volume

Moreover, Quest's consistently limp revenue and testing-volume growth over the past several quarters prompted it to cut by .5 percent its 2011 revenue growth projection, and caused it to debut a three-year, half-billion-dollar cost-cutting plan.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.